Matsumura and colleagues found that c-Kit was the only RTK that is significantly expressed in high-grade neuroendocrine carcinomas of the lung, including both large cell neuroendocrine carcinoma (LCNEC) and SCLCs, but not in NSCLC (Matsumura et al., 2015). This evidence concerns the gene KIT and large cell neuroendocrine carcinoma.